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Perturbations in cell-cell contact machinery occur frequently in epithelial cancers and result in increased cancer cell migration and
invasion. Previously, we demonstrated that MMP-7, a protease implicated in mammary and intestinal tumor growth, can process
the adherens junction component E-cadherin. This observation leads us to test whether MMP-7 processing of E-cadherin could
directly impact cell proliferation in nontransformed epithelial cell lines (MDCK and C57MG). Our goal was to investigate the
possibility that MMP-7 produced by cancer cells may have eﬀects on adjacent normal epithelium. Here, we show that MMP-7
processing of E-cadherin mediates, (1) loss of cell-cell contact, (2) increased cell migration, (3) a loss of epithelial cell polarization
and (4) increased cell proliferation via RhoA activation. These data demonstrate that MMP-7 promotes epithelial cell proliferation
via the processing of E-cadherin and provide insights into the molecular mechanisms that govern epithelial cell growth.
1.Introduction
The matrix metalloproteinase (MMP) family of zinc-de-
pendent enzymes comprises 23 members in man [1].
Although MMPs are typically thought of as degradative
enzymes with the ability to cleave extracellular matrix
proteins such as collagen and ﬁbronectin, recent literature
suggests that their dominant role is actually as signal-altering
molecules [2]. MMP-7, in particular, has several in vivo-
veriﬁed substrates, none of which are typical extracellular
matrixproteins[3].Thesenonmatrix-degradingfunctionsof
MMPs vastly expand the ways in which they can contribute
to various pathologies, including tumor progression. In
previous studies we have identiﬁed several growth and death
factors as substrates for MMP-7 that aﬀect tumor behavior
[4–7]. In addition, we identiﬁed the adhesion molecule E-
cadherin as an MMP-7 substrate and showed that one of
the products of E-cadherin cleavage, the 80kDa ectodomain,
could promote invasive activity in a paracrine fashion [8].
These previous studies were all performed in transformed
cells.ThisledustoquestionwhetherthefunctionsofMMP-7
are similar in nontransformed cells. This is an important
question since MMP-7 is a secreted proteinase, and it is likely
that its release from cancer cells could aﬀect adjacent normal
tissue.
E-cadherin is the prototypical epithelial adhesion
molecule [9, 10]. One of its functions is to sense cell:cell con-
tact and thus limit density. E-cadherin can be modulated in
many ways, including methylation of the promoter resulting
in downregulation [11], gene mutation as seen in familial
gastric carcinoma [12], downregulation of expression by
binding of transcription factors such as Snail and Slug
to the promoter [13], and extracellular proteolysis [14].
This last process results in the production of the afore-
mentioned 80kDa ectodomain fragment that is detectable
in the serum and urine of cancer patients and has been
proposed as a biomarker [15]. Several proteinases are known
to cleave E-cadherin including MMPs-3 and -7 [8, 16],2 Journal of Oncology
ADAMs-10 [17]a n d- 1 5[ 18], cathepsins B, L, and S [19],
and the serine proteinases plasmin [20] and kallikreins-6
[21] and -7 [22]. It is typically thought that such E-cadherin
processingresultsincellswithenhancedmigratorypotential;
however functions of E-cadherin other than adhesion are
also aﬀected by proteolytic events. Previous studies have
suggested that downregulation of E-cadherin in tumor cells
leads to a reduction in levels of the cyclin-dependent kinase
inhibitor p27kip1 and ultimately enhanced proliferation [23].
Here we use nontransformed epithelial cell lines to test
whetherproliferationisalteredwhenE-cadherinisprocessed
by MMP-7. We demonstrate that E-cadherin cleavage by
MMP-7 initiates an alternative proliferative pathway that
bypasses p27 but results in enhanced RhoA activity and
increased cyclin D1 levels. Thus, in addition to enhanced
migratory ability, a predominant result of MMP-7-mediated
E-cadherin cleavage is loss of contact inhibition and an
increase in proliferation indicating that MMP-7 cleavage of
E-cadherin can regulate growth potential of nontransformed
cells.
2.MaterialsandMethods
2.1. Cell Lines and Culture Conditions. Madin Darby Canine
Kidney (MDCK) and the mammary gland cell line derived
from a C57BL/6 mouse (C57MG) cells have been described
[24, 25]. Retroviral transduction was used to generate clones
of C57MG cells stably expressing MMP-7 as previously
described [4]. All cells were maintained in DMEM con-
taining 10% fetal calf serum at 37
◦C, with a 5% CO2-
humidiﬁed atmosphere. For experiments where serum-free
conditions were required, the growth medium was removed,
and cells were rinsed with PBS and then refed with OPTI-
MEM medium (Invitrogen, Carlsbad, CA) containing no
serum. To generate polarized monolayers of MDCK and
C57MG cells, 2 × 106 cells were plated on the upper surface
of 0.4μm Transwell ﬁlters (Corning, Lowell, MA) in 6-well
plates. The resistance of the cultures was measured daily
using an epithelial volt ohmmeter (World Precision Instru-
ments, Sarasota, FL). The MDCK cell layer was considered
polarized when the trans-epithelial resistance was greater
than 200Ω · cm2. For all experiments where recombinant
MMP-7 (Calbiochem/EMD Chemicals, Gibbstown, NJ) was
added to cultures, a concentration of 100ng/mL was used.
2.2. Cell Growth and Proliferation Assays. Growth rates of
the C57MG clones were determined by plating 104 cells in
6-well plates (for low density) or 5 × 104 cells in 12-well
plates (for high density), and viable cells were counted using
ahemocytometereverytwodaysfor10days.Furtheranalysis
of the C57MG clones was performed using the Cell Titer 96
Aqueous Nonradioactive cell proliferation assay (Promega,
Madison, WI), according to the instructions provided by the
manufacturer. For these assays, 5 × 103 cells were seeded
per well in 96-well plates. The matrix metalloproteinase
inhibitor BB-94 (a gift from Dr Peter Brown, British Biotech
plc, Oxford, UK) was added at time of seeding to replicate
wells at either 2.5 or 5μM to determine the contribution
of matrix metalloproteinase activity to proliferation. Control
wells received equivalent volumes of the vehicle, dimethyl-
sulfoxide. To test the contribution of E-cadherin, an E-
cadherinblockingantibody(Decma-1,Sigma,StLouis,MO)
or control rat IgG (Sigma) was added to replicate wells at a
concentration of 40mg/mL. Prior to adding the antibodies,
cells had been serum-starved for 24hours, then incubated
with 5mM EGTA (Sigma) for 30mins to disrupt adherens
junctions. Thymidine incorporation assays were used as an
indicatorofproliferationrateofpolarizedMDCKcells.Once
polarization had been conﬁrmed, MDCK cells were serum-
starved for 24hrs, then treated with 100ng/mL recombinant
active human MMP-7 (EMD Chemicals, Gibbstown, NJ)
added to either the apical or basal compartment. A second
addition of MMP-7 occurred after 18hrs. Four hours later,
the transepithelial resistances were measured, and 1.0mCi of
methyl-3H-thymidine (Perkin-Elmer/NEN, Waltham, MA)
was then added to the basal surface of all cells. After 3 hours,
the ﬁlters were washed in ice-cold 10% trichloroacetic acid
(Sigma),driedandthenincubatedovernightin0.2Nsodium
hydroxide. Aliquots of the supernatant were then removed
for scintillation counting.
2.3.MigrationAssay. C57MG cells were removed from tissue
culture ﬂasks with 5mM EDTA. After washing with PBS,
the cells were resuspended in serum-free medium and
1.5 × 104 cells were placed on the upper surface of 8.0μm
Transwell ﬁlters in 24-well plates (Corning). In the lower
chamber, 1mL of DMEM containing 10% FBS was used
as a chemoattractant. The cells were then incubated for 6
hours at 37
◦Ci na5 %C O 2 humidiﬁed incubator. After
incubation, the cells on the upper surface of the membrane
were removed with a cotton-tipped swab. The membranes
were cut out of the chamber, and the cells on the lower
surface were ﬁxed in 100% methanol at −20
◦Cf o r7m i n u t e s
and stained with hematoxylin and eosin. The membranes
were then dehydrated through a series of ethanol solutions
andmountedonslidesusinganaqueousmountingmedium.
Migrating cells were then viewed under the microscope at
10x magniﬁcation, and the number of migrating cells per
ﬁlter was determined.
2.4. Western Blotting and Immunoprecipitation. For analysis
of E-cadherin, cyclinD1, and p27kip1 expression, conﬂuent
cultures of MDCK cells treated with or without recombi-
nant human MMP-7 were lysed in lysis buﬀer (0.5% NP-
40, 100mM NaCl, 50mM Tris-HCL, pH 7.5, containing
a protease inhibitor cocktail (Roche, Indianapolis, IN)),
and 30μg of total protein was electrophoresed through
SDS-polyacrylamide gels. For the C57MG clones, 104 cells
were inoculated into 6-well plates and after 8 days (the
time point identiﬁed at which the clones were conﬂuent
(Figure 3(c)) cell lysates were harvested in a similar manner
to those described for MDCK. Proteins were transferred to
PVDF membranes for detection. Anti-p27kip was used at a
1:2,500 dilution (clone 57, BD-Transduction, San Diego,
CA), anticyclin D1 (Santa Cruz Biotechnology, Santa Cruz,
CA) was used at 1:1000, while anti-E-cadherin was used at
1:500 (Decma-1, Sigma).Journal of Oncology 3
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Figure 1: MMP-7 expression disrupts adherens junctions. (a) Representative photomicrograph (400x) of β-catenin immunoﬂuorescent
staininginMDCKcellsintheabsenceorpresenceofexogenousMMP-7(100ng/mL).Arrowsindicatejunctionalβ-catenin.(b)Immunoblot
analysis of MMP-7 (27kDa) expression (upper panel) in empty vector control (L2 and L4) and MMP-7 (M14 and M37) transduced C57MG
cell lines. Zymography (lower panel) was used to examine the expression of MMP-2 (72kDa) and MMP-9 (92kDa). (c) Representative
photomicrographs (400x) of E-cadherin (green) and β-catenin (red) immunoﬂuorescent staining (arrows) in the vector control (L2/L4)
and MMP-7 (M14/37) expressing cells. Arrows indicate junctional E-cadherin and β-catenin. (d) The impact of MMP-7 expression on cell
migration through 8μm pore membranes (arrow heads) towards 10% serum-containing media was determined.
∗P <. 05, as determined
by ANOVA followed by Tukey’s post hoc test.
For detection of soluble E-cadherin in conditioned
medium from C57MG clones, E-cadherin was immunopre-
cipitated from 3mls of medium that had been conditioned
for 48 hours. To reduce background, samples were incu-
bated with 100μL of protein A-sepharose (25mg/mL stock,
Amersham/GE Healthcare, Piscataway, NJ) in immunopre-
cipitation (IP) buﬀer (50mM Tris pH 7.5, 100mM NaCl,
0.5% NP-40) at 4◦C for 1 hour. Precleared lysates were
then incubated with 1μg of anti-E-cadherin (Decma-1) for
1 hour. After this step, 200μL of protein A-sepharose beads
wasadded, and thesampleswereincubatedovernight at4◦C.
The immunoprecipitates were analyzed by Western blotting
using the anti-E-cadherin antibody (Decma-1) as described
above.
2.5. Immunoﬂuorescence. A l lc e l ll i n e sw e r ep l a t e da tc o n ﬂ u -
ent densities (5 ×103cells/well) in an 8-well plastic chamber
slide (LabTek, Thermo Fisher Scientiﬁc, Pittsburgh, PA).
After 24 hours, the cells were examined for E-cadherin or
β-catenin localization using immunoﬂuorescence. The cells
were rinsed once in PBS and were ﬁxed for 7 minutes at
−20
◦C in 100% methanol. The methanol was removed and
the cells were washed twice in PBS for 5 minutes with
shaking at room temperature. All subsequent washes were
performed with shaking. The cells were then incubated
for 30 minutes at room temperature using a 3% blocking
solution (3% milk in PBS). The cells were then washed four
times for 5 minutes with PBS. After washing, the cells were
incubated with the primary antibodies (β-catenin: 1:250
dilution, BD-Transduction; E-cadherin 1:100, Sigma) for
1 hour at room temperature. The cells were then washed
four times for 5 minutes in PBS. A Cy3-labeled antimouse
secondary antibody (Invitrogen) was added at a dilution
of 1:1000 for 30 minutes at room temperature. The slides
were then washed four times for 10 minutes in PBS with
shaking. After the ﬁnal wash, the slides were covered with an
aqueous mountant (Gel/Mount, Biomeda, Burlingame, CA),
coverslipped and viewed with a ﬂuorescent microscope.4 Journal of Oncology
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Figure 2: Epithelial polarization is negatively impacted by MMP-7. (a) Analysis of MDCK polarization in response to the addition of
basolateral or apical exogenous MMP-7 (100ng/mL) to the lower or upper compartment of the transwell chamber,
∗P <. 05 as determined
by ANOVA followed by Bonferroni’s post hoc test. Dashed line represents the resistance level at which MDCKs are polarized [7]. (b) Analysis
of C57MG cell line transepithelial resistance in response to the expression of MMP-7. Conﬂuent (day 8) MMP-7 expressing clones (M14 and
M37) growing on a 0.4μm transwell membrane never reached a resistance that was comparable to that of the empty vector control C57MG
clones.
2.6. RhoA Activity Assays. To assess changes in the activation
status of RhoA, rhotekin pull-down assays were used as
described [26]. Brieﬂy, 10cm plates of C57MG clones
under preconﬂuent or conﬂuent conditions, or MDCK
cells exposed to 100ng/mL recombinant active MMP-7 for
diﬀerent periods of time, were lysed in 1% NP-40, 50mM
Tris, pH 7.4, 10% glycerol, 100mM NaCl, and 10mM
MgCl2.Arhotekinbindingdomain-glutathioneStransferase
(RBD-GST) fusion protein (vector kindly supplied by Dr
Neil Bhowmick, Vanderbilt University) was precoupled to
agarose-glutathione beads (Sigma) and used to adsorb the
GTP-bound (active) form of RhoA from the lysates. Total
RhoA levels from nonadsorbed lysates as well as the bead-
adsorbed active RhoA was detected by immunoblotting
using a RhoA antibody from Santa Cruz Biotechnology.
As a positive control for these assays, cells were treated
with lysophosphatidic acid (LPA), known to simulate Rho A
activation [26], for 5mins.
2.7. Statistical Analysis. All analysis was performed, and
graphs generated using Prism 5 software (Graphpad soft-
ware, San Diego, CA). Signiﬁcance was deﬁned at the 95%
level of conﬁdence. For all experiments, a minimum of
3 replicates per condition was used. Each experiment was
repeated at least twice. For comparisons between 2 groups,
Student’s t-test was used. Nonparametric data were com-
pared using the Mann-Whitney test. One-way ANOVA with
Bonferroni or Tukey post hoc test (indicated in appropriate
Figure Legends) was used for analyzing data from multiple
groups. Data are shown as mean ± standard deviation.
3. Results
3.1. MMP-7 Disrupts Epithelial Adherens Junctions and
Promotes a Migratory Phenotype. The MDCK cell line is
a nontransformed, nontumorigenic canine kidney cell line
that does not express MMP-7 endogenously and has been
extensively utilized as an in vitro model to study adherens
junction biology [7, 24]. Using conﬂuent MDCK cells,
we observed by immunoﬂuorescence that the addition of
exogenous MMP-7 resulted in a loss of cell-cell contact
as assessed by immunoﬂuorescent localization of β-catenin
(Figure 1(a)). To ensure that this eﬀect was not speciﬁc
to the MDCK cell line, we employed another nontrans-
formed, nontumorigenic mammary gland epithelial cell line,
C57MG, that does not endogenously express MMP-7 [4]. To
more accurately reﬂect the in vivo scenario of endogenous
MMP-7 expression, we generated C57MG clonal cell lines
that were either negative (L2, L4) or positive (M14, M37) for
MMP-7 expression (Figure 1(b)). Importantly, we observed
that the endogenous expression of MMP-7 in the C57MG
cell line did not impact the expression of other MMPs such
as MMP-2 and MMP-9. Concomitant with our observations
in the MDCK cell line, the endogenous expression of
MMP-7 resulted in a loss of adherens junction formation
as assessed by E-cadherin and β-catenin immunoﬂuorescent
localization in the MMP-7 expressing clones (Figure 1(c)).
Analysis of the migratory phenotype of the C57MG cell
lines also demonstrated that MMP-7 expression signiﬁcantly
promoted migration toward serum containing media (L2;
81.3 ± 8.50, L4; 96 ± 28.0 versus M14; 239 ± 56.0, M37;
217.3 ± 55 migrating cells per ﬁlter, Figure 1(d)). These
data identify that the addition of exogenous recombinant
active MMP-7, or the forced expression of MMP-7, results
in a disruption of the adherens junction and an increase in
cellular migration in nontransformed epithelial cell lines.
3.2.EpithelialCellPolarizationIsCompromisedinthePresence
of MMP-7. Epithelial polarization is critical for the proper
cell function and the formation of tight adherens junctions
are key for this process. Therefore, given that MMP-7
appeared to be mediating the disruption of the adherensJournal of Oncology 5
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Figure 3: MMP-7 enhances the proliferation of nontransformed epithelial cells. (a) Analysis of proliferation using [3H]-thymidine of
conﬂuent MDCK (grown on 0.4μm transwell membrane) upon addition of exogenous MMP-7 (100ng/mL) to the basolateral (lower
chamber) or apical surface (upper chamber).
∗P <. 05 as determined by one-way ANOVA with Bonferroni post hoc test. The values
represent scintillation counts corrected for amount of protein present. (b) Representative photomicrographs of vector control (L2/L4) and
MMP-7expressing(M14/37)C57MGcellsundersubconﬂuentandconﬂuentconditions(200x).(c)Theaveragecellcountsofvectorcontrol
(L2 and L4) and MMP-7 (M14 and M37) expressing C57MG cell lines over time. ANOVA analysis followed by Bonferroni’s post hoc analysis
of the numbers of cells in each group at the day 10 time point revealed that the M14 and M37 cell lines reached signiﬁcantly higher numbers
of cells (P<. 05).
junction, we examined whether addition or expression of
MMP-7 impacted the ability of nontransformed epithelial
cell lines to polarize. Our results show that the addition of
MMP-7 to the basolateral compartment (lower chamber)
of conﬂuent MDCK cells grown on a 0.4μmm e m b r a n e
resulted in a loss of polarization compared to the control
cells or to the addition of MMP-7 to the apical surface
(Control;284 ± 48.1versusMMP-7-Basolateral;200 ± 39.9
versus MMP-7-Apical; 256.0 ± 26.5Ω · cm2, Figure 2(a)).
In addition, we observed that MMP-7 expression by the
C57MG clones, M14, and M37 also impacted the tightness
of the monolayer formed by conﬂuent C57MG cell lines
as determined by epithelial resistance measurements (L2;
152 ± 6.48, L4; 155 ± 5.430 versus M14; 104 ± 9.67, M37;
109 ± 4.99Ω · cm2, P<. 05, Figure 2(b)). These data are in
agreement with our observations examining the disruption
of the adherens junctions by the addition or expression of
MMP-7 and further perturbation of the adherens junctions
negatively impacts the ability of nontransformed epithelial
cells to form tight cell: cell junctions necessary for polariza-
tion.
3.3. MMP-7 Promotes Epithelial Proliferation In Vitro. Cell-
cell contact is a negative regulator of proliferation [27].
Since MMP-7 perturbed the ability of epithelial cells to form
stableadherensjunctionsandpolarize, wetestedwhetherthe
exogenous addition or expression of MMP-7 enhanced the
proliferation of MDCK and C57MG cells. Using a transwell
system, MDCK cells were grown to conﬂuence, that is,
contact inhibition, and we observed that the addition of6 Journal of Oncology
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Figure 4: MMP-7 promotes E-cadherin processing. (a) Detection of the ectodomain of E-cadherin (80kDa, open arrow head) in the
conditioned media of MDCK cells in the presence (+) or absence (−) of exogenous MMP-7 (100ng/mL). (b) Analysis of E-cadherin
processing in the empty vector control (L2 and L4) and MMP-7 (M14 and M37) expressing cell lines. Open arrow head indicates the
ectodomain of E-cadherin (80kDa) in conditioned media, while arrow and arrow head indicate full length E-cadherin (120kDa) and
intracellular fragment of E-cadherin (40kDa), respectively, in C57MG cell line lysates.
MMP-7 to the basolateral surface promoted the proliferation
of the MDCK cells compared to the addition of MMP-7 to
the apical surface or control conditions as assessed by [3H]-
thymidine corporation (Control; 350 ± 28.0 versus MMP-
7-Basolateral; 533 ± 93.0 versus MMP-7-Apical; 353.3 ±
42.7 counts per minute/mg total protein as measured in
scintillation counter, Figure 3(a)). These data suggest that
disruption of cell:cell adhesion is suﬃcient to facilitate the
proliferation of contact-inhibited MDCK cells.
The eﬀect of MMP-7 expression on the proliferation
of the C57MG cell line was also determined. Interestingly,
preconﬂuent analysis showed no morphological diﬀerences
between the empty vector control and MMP-7 expressing
C57MG clones, but it appeared that MMP-7 expression
conferred the C57MG cells with an ability to grow to a
much higher cell saturation density (Figure 3(b)). Analysis
of the logarithmic growth of the cells over time using trypan
blue exclusion assays revealed that the average doubling time
for each of the cell lines was L2; 34.8 ± 1.00, L4; 28.1 ±
1.50 versus M14; 25.6 ± 0.50, M37; 24.1 ± 1.00 hours.
Statistical analysis revealed that the MMP-7 expressing cell
lines had a signiﬁcantly faster doubling time (P = .002)
and grew to signiﬁcantly higher cell densities compared to
the empty vector control cell lines (Figure 3(c)). These data
demonstrate that the MMP-7 can promote the proliferation
of nontransformed epithelial cells.
3.4. E-Cadherin Is Processed by MMP-7 in Nontransformed
EpithelialCellLines. The adherens junctionin epithelial cells
contains numerous complexes that allow the formation of
tight cell-cell contacts. Previously, we identiﬁed that MMP-7
was capable of processing E-cadherin in transformed cells,
at the juxtamembrane region, resulting in the generation
of 80kDa ectodomain and 40kDa intracellular domain
fragments [8]. Therefore, we next tested whether MMP-7
was responsible for E-cadherin processing in the MDCK
and C57MG cells. We observed byimmunoprecipitation that
the addition of exogenous MMP-7 to conﬂuent MDCK cells
resulted in the shedding of the E-cadherin ectodomain into
the conditioned media (Figure 4(a)). In conﬂuent MMP-7
expressing C57MG cell lines, we also identiﬁed signiﬁcantly
higher levels of the E-cadherin ectodomain in conditioned
media compared to the empty vector control cell lines
(Figure 4(b)). In agreement with enhanced shedding of the
ectodomain, we identiﬁed higher levels of the 40kDa intra-
cellulardomainintheMMP-7expressingcelllinescompared
to the control (Figure 4(b)). These data demonstrate that
MMP-7 mediates E-cadherin processing in nontransformed
epithelial cell lines.
3.5. Epithelial Cell Proliferation Is Potentiated by MMP-7
and E-Cadherin. Collectively, our data demonstrate that
MMP-7 promotes disruption of the adherens junction that
in turn results in a loss of epithelial polarization and
increased proliferation. Given that MMP-7 can mediate E-
cadherin processing, we next examined whether the eﬀects
on epithelial cell proliferation were related to the E-cadherin
cleavage.We ﬁrstconﬁrmedthatthe proliferation phenotype
directly resulted from metalloproteinase activity. To this end,
theemptyvectorandMMP-7expressingC57MGcloneswere
incubatedinthepresenceorabsenceofthemetalloproteinase
inhibitor, BB-94. Over 24 hours, we identiﬁed that treatmentJournal of Oncology 7
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Figure 5: Epithelial proliferation is mediated by MMP-7 processing of E-cadherin. (a) Growth of the C57MG cell lines in the presence or
absence of the broad spectrum metalloproteinase inhibitor (BB-94) over a 24-hour period was determined by MTT assay. Asterisk denotes
that the proliferation of the MMP-7 expressing cell lines (M14/M37) is signiﬁcantly higher than the empty vector controls (L2/L4), P<. 05
while double asterisks denote that proliferation is signiﬁcantly inhibited in the presence of BB-94 compared to the control conditions,
P<. 05. Signiﬁcance was determined using ANOVA followed by Tukey’s post hoc test. (b) The eﬀe c to fE - c a d h e r i no nc e l lg r o w t hi nt h e
absence (IgG) or presence of an E-cadherin blocking antibody (α-E-cad) was measured using an MTT assay. Asterisk denotes signiﬁcantly
higher growth in the presence of the E-cadherin blocking antibody in comparison to the IgG treated controls, P<. 05. Signiﬁcance was
determined using ANOVA followed by Tukey’s post hoc test.
with BB-94 (5μM) reduced the proliferation of the MMP-7
expressing cell lines to the level of the control empty vector
cell lines suggesting that metalloproteinases could promote
the proliferation of nontransformed mammary epithelial
cells directly as assessed by MTT assay (L2 Control: 1.74 ±
0.25 versus L2 BB-94 5μM: 1.8 ± 0.15, L4 Control: 2.04 ±
0.13 versus L4 BB-94 5μM: 2.01 ± 0.15, M14 Control:
2.51 ± 0.27 versus M14 BB-94 5μM: 1.993 ± 0.06, M37
Control 2.75 ± 0.21 versus M37 BB-94 5μM: 2.237 ±
0.10 ABS at 490nm, Figure 5(a)). Of note, BB-94 did not
impact the proliferative ability of the empty vector control
cell lines (Figure 5(a)), thus suggesting that MMP-7 is the
metalloproteinase promoting the proliferative phenotype in
these cells.
To then test whether perturbation of E-cadherin could
directly mediate cell proliferation in the C57MG clones,
conﬂuent cultures were pretreated with EGTA in order
to disrupt the homotypic E-cadherin binding and then
returned to normal culture conditions in the presence or
absence of an E-cadherin blocking antibody that prevented
E-cadherin binding between cells. The results demonstrate
that the blocking of E-cadherin signiﬁcantly promoted the
growth of conﬂuent empty vector control C57MG cell lines
but had no impact on the growth of the MMP-7 expressing
clones compared to respective controls incubated with
control antibody (L2 IgG: 0.79 ± 0.06 versus L2 α-E-cad:
1.25 ± 0.07,L4IgG:1.08 ± 0.03versusL4α-E-cad:1.415 ±
0.02,M14IgG:1.30 ± 0.03versusM14α-E-cad:1.48 ± 0.02,
M37 IgG 1.2 ± 0.07 versus M37 α-E-cad: 1.45 ± 0.10 ABS
at 490nm, Figure 5(b)). Thus, MMP-7 expression rendered
the E-cadherin blocking antibody impotent, indicating that
E-cadherin is downstream of MMP-7.
Overall, these data demonstrate that MMP-7 can pro-
mote cell proliferation and that the molecular mechanism
underlying this observation is due, in part, to the perturba-
tion of E-cadherin mediated cell-cell contact.
3.6. E-Cadherin Mediates Epithelial Cell Proliferation in a
RhoA Dependent Manner. Our data suggest that MMP-7
processing of E-cadherin mediated the proliferation of non-
transformed epithelial cells. Next, we examined the precise
molecular mechanism through which E-cadherin mediated
this eﬀect. Previous reports have identiﬁed that E-cadherin
can regulate cell cycle progression via negative regulation
of the cell cycle inhibitor, p27kip1 [28]. However, analysis of
lysatesderivedfromcontrolandMMP -7-treatedMDCKcells
and from the empty vector control and MMP-7 expressing
mammary epithelial cells revealed no major diﬀerences in
the levels of p27kip1 (Figure 6(a)). In separate experiments,
no changes in cytosolic versus nuclear p27kip-1 were observed
(data not shown). Several studies have tied RhoA activity
status to E-cadherin function [29–35], which prompted us
to analyze the activity of RhoA in both the MDCK cells
after treatment with exogenous MMP-7, and in the C57MG
control and MMP-7-expressing clones. We detected height-
ened RhoA activity (normalized to total RhoA) compared
to controls in both cases (Figure 6(b)). We then used the
C57MG clones to test whether the enhanced RhoA activity
was downstream of E-cadherin. In the C57MG empty vector
control cell line, blocking E-cadherin homotypic binding via
the addition of blocking E-cadherin antibodies signiﬁcantly
enhanced RhoA activation in comparison to IgG-treated
controls (Figure 6(c)). An identical result was achieved when
control cells were treated with recombinant active MMP-
7. As expected, in cells already expressing MMP-7 in which
E-cadherin is already perturbed, neither blocking antibody
nor addition of exogenous MMP-7 had any eﬀect on RhoA
activity (Figure 6(c)). Thus, perturbation of E-cadherin by8 Journal of Oncology
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Figure 6: MMP-7 cleavage of E-cadherin does not aﬀect p27kip-1 levels but enhances RhoA activity. (a) Change in p27kip-1 levels in polarized
MDCK cells over time (hours, h) in the absence (−) or presence (+) of exogenous MMP-7 (100ng/mL) was assessed by immunoblot
analysis of the cell lysates (upper panel). p27kip-1 levels (arrow) in cell extracts of conﬂuent vector control and MMP-7 expressing cell lines
werealsoexamined(lowerpanel).(b)Changeinconﬂuent-polarizedMDCKRhoAactivityinresponsetotheadditionofexogenousMMP-7
(100ng/mL) over time (minutes, min) was examined using a Rhotekin pull down assay as described in the materials and methods followed
by immunoblot analysis for active RhoA. Direct immunoblot analysis for total RhoA served as a control for loading. Arrow and arrowhead
indicate active and total RhoA, respectively. LPA was used as a positive control for RhoA activity. The level of active RhoA in conﬂuent vector
control and MMP-7 expressing cell lines was also determined. (c) RhoA activity (arrow) in lysates obtained from conﬂuent empty vector
control and MMP-7 expressing cell lines treated either with IgG control or with E-cadherin blocking (α-E-cad) antibodies in addition to
exogenous MMP-7 (100ng/mL) for 1 hour was examined using the rhotekin pull down assay followed by immunoblot analysis of RhoA
(upper panel). Total RhoA (arrowhead) and actin (open arrow head) levels were examined by direct immunoblot analysis of the cell lysates
and served as a loading control. (d) Analysis of cyclin D1 (arrowhead) levels in whole cell lysates derived from preconﬂuent and conﬂuent
empty vector control and MMP-7 expressing cell lines. Actin was used as a loading control (open arrowhead).
either antibody blockade or MMP-7-mediated processing
results in the activation of RhoA.
RhoA activity has long been implicated in regulation
of cell cycle progression by multiple pathways including
increased levels of cyclin D1 [36]. Since p27kip1 levels were
unchanged, we therefore examined the levels of cyclin D1
in the C57MG control and MMP-7-expressing clones. Our
data demonstrate that in both preconﬂuent and conﬂuent
C57MG cell lines, MMP-7 expression is associated with
enhanced levels of cyclin D1 (Figure 6(d)). Collectively,
these data suggest that MMP-7 processing of E-cadherin
in nontransformed cells leads to the perturbation of the
adherens junction, increased RhoA activity, and higher levels
of cyclin D1 expression that in turn result in enhanced
proliferation.
4. Discussion
Unchecked cell proliferation is a hallmark of epithelial
tumorigenicity and tumor progression. Identiﬁcation of the
mechanisms that regulate how epithelial cells proliferate and
grow is key to understanding the epigenetic changes that
drive cancer. The formation of tight adherens junctions
between epithelial cells is essential for proper function of
the epithelium. Studies have identiﬁed that disruption of
the adherens junction by proteinases in epithelial cells can
lead to a more migratory function but it is unclear if the
perturbation of the cell-cell contact machinery can also lead
toproliferationin nontransformedepithelial cells[8,16,17].
In the current study we have shown that inhibition of the
function of a critical component of the adherens junction,Journal of Oncology 9
E-cadherin, via proteolytic processing by MMP-7 promotes
epithelial cell proliferation via enhanced RhoA activity and
cyclinD1 expression.
In addition to its well-understood adhesive function, E-
cadherin is an important regulator of cell signaling [37, 38].
Catenins, the other main components of adherens junctions,
are important signaling molecules whose activity is modu-
lated by their interaction with E-cadherin. For example, β-
catenin when not bound by E-cadherin can participate in
Wnt signaling [38], and p120-catenin is a critical regulator
of Rho and Rac-GTPases [39]. Notably, E-cadherin blockade
by neutralizing antibody does not lead to dissociation of β-
catenin from the adherens junctions [23]. We also saw no
signiﬁcant changes in β-catenin by western blot analysis after
exposing our cells to MMP-7 (data not shown). A likely
explanation is that in these nontransformed cells, without a
Wnt signal, any β-catenin released from the junctions will
be ubiquitinated and degraded. Recent evidence suggests
that both intra- and extracellular fragments of E-cadherin
itself participate in signaling directly through activation of
ErbB receptors [18] and nuclear activity of the p120/kaiso
complex [40], respectively. A well-studied consequence of
E-cadherin-regulated signaling is proliferation. One method
by which this occurs is via upregulation of the cell cycle
inhibitor p27kip1, which has been described as a major
mechanism of contact inhibition [23]. However, it is clear
that the same pathways are not operational in all cells.
Indeed, a recent report suggests that E-cadherin and p27kip1
actually have an inverse relationship in renal and other
cancer cells, so that increased E-cadherin is associated with
reduced p27kip1 [41]. In the two cell lines used in this report,
renal MDCK cells and mammary C57MG cells, there was
no apparent change in p27kip1 levels following E-cadherin
cleavage. Instead, RhoA activation was seen as a direct result
of E-cadherin perturbation either by blocking antibodies
or MMP-7 cleavage. Changes in Rho-GTPase activity have
previously been associated with loss of E-cadherin adhesive
function [29–31, 33]. Unsurprisingly, the activation of RhoA
can contribute to the migratory phenotype via control of
the actin cytoskeleton [9, 31]. However, RhoA activation
has also long been known to inﬂuence cell cycle progression
[36]. This can occur via promotion of the degradation of
cell cycle inhibitors such as p21 and p27kip1 or via increased
gene expression of cell cycle promoters such as cyclin D1
[36, 42–44]. In our cell lines, increased cyclinD1 seems to be
the major result of the MMP-7-initiated E-cadherin/Rho A
activation pathway.
Our data identify that MMP-7 mediates cell proliferation
via the processing of E-cadherin in nontransformed epithe-
lial cells, a conclusion that is supported by our data using
E-cadherin blocking antibodies (Figure 5). However, the
possibility that MMP-7 can promote proliferation via other
mechanisms is also likely given that the proteinase has a wide
variety of substrates [2]. In fact we have recently shown that
under three-dimensional (3D) culture conditions, MMP-7
processing of heparin bound epidermal growth factor in the
C57MG cells is responsible for promoting cell proliferation
via the ErbB4 receptor [4]. Intriguingly, this eﬀect is not
apparent under 2D conditions. Therefore, in vivo it is
plausible that MMP-7 expression results in the initiation
of a cellular program that cumulatively is responsible for
the initiation of proliferation in normal epithelial cells.
This supposition of MMP-7 as an eﬀector of this program
is further supported by studies demonstrating how E-
cadherin and ErbB receptors work in concert to orchestrate
proliferation [45, 46].
In previous studies, we identiﬁed that MMP-7 processing
of E-cadherin leads to enhanced cell migration [8]. Fur-
thermore, we observed that the ectodomain of E-cadherin
was responsible for promoting the migratory phenotype
since the immunodepletion of the soluble ectodomain of E-
cadherin reestablished E-cadherin function. The results of
the current study using a nontransformed mammary gland
epithelial cell line are in agreement with the concept that
MMP processing of E-cadherin leads to the disruption of
the adherens junction and the induction of cell migration.
However, it is possible that the soluble ectodomain of E-
cadherin may mediate other cellular eﬀects. For exam-
ple, the ectomain fragment released by a disintegrin and
metalloproteinase-15 (ADAM-15) processing of E-cadherin
can bind to the ErbB receptors, ErbB2 and ErbB3, and
stimulate proliferation. The approximate molecular weights
of the E-cadherin ectodomains generated by MMP-7 and
ADAM-15 are similar in size; however it is possible that
variations in the precise amino acid sequence at the cleavage
site may dictate the biological eﬀects of the generated E-
cadherin ectodomain [18]. Furthermore, we and others
have also shown that E-cadherin is susceptible to pro-
cessing by MMP-3 while others have shown that ADAM-
10, cathepsins, and serine proteases can also promote E-
cadherin processing [8, 16, 17, 19–22]. Therefore, whether
the processing of E-cadherin by proteinases is a means
of regulating speciﬁc E-cadherin functions or represents
a substrate overlap between proteinases requires further
investigation. Nevertheless, our studies and others linking E-
cadherin processing to migration and proliferation support
the role of MMP-7 in initiating a cell proliferation program
in nontransformed epithelial cell lines.
Interestingly,ourdataidentifythattheadditionofexoge-
nous MMP-7 to the basolateral rather than the apical surface
oftheMDCKcellsresultsintheprocessingofE-cadherinand
subsequentincreasedproliferation.This observation appears
contrary to our earlier studies in the MDCK cell line that
indicated overexpression of MMP-7 promoted proliferation
via an apical but not basolateral pathway [7]. In that study
however, the overexpressed MMP-7 was in the pro- or latent
form. Conversion to the active enzyme was only evident
at the apical surface which would explain why no eﬀects
were seen at the basal surface. However, our observation
here that when active MMP-7 interacts with proteins on
the basolateral surfaces, a proliferative eﬀect can be seen
suggests that the expression of MMP-7 by stromal cells may
impact the behavior of the normal epithelium. While MMP-
7 is often expressed by glandular epithelium, it has also
been shown to be highly expressed by macrophages and
osteoclasts [47–49]. In addition, we have previously reported
that basement membrane integrity is disrupted in transgenic
mice overexpressing MMP-7 in the mammary epithelium10 Journal of Oncology
suggesting that this MMP can also impact the integrity of
the basolateral compartment [6]. Therefore, it is possible
that in the context of inﬂammation or infection, MMP-7
secretedfromothercellularsourcesmayreachthebasolateral
compartment of the epithelium and promote epithelial cell
migration and proliferation.
In addition to identifying roles for E-cadherin in the
proliferation of nontransformed epithelial cells, the ﬁndings
of the current study also have implications for pathological
disease. For example, MMP-7 is often expressed by glandular
epithelium including those of the breast and colon [49],
and we have previously identiﬁed that MMP-7 can promote
mammary gland and colon tumorigenesis [50, 51]. There-
fore, given the ﬁndings of the current study, it is plausible
that the aberrant expression of MMP-7 could result in the
initiation of a cellular program that promotes epithelial
proliferation and migration, and that MMP-7 processing of
E-cadherin is a molecular eﬀector of this program.
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